0 CHECKOUT

PRODUCT FILTERS

REGION

23
4
3
3
3

COUNTRY

PRICE

2
46
84
164

PUBLISHED

58
65
86
164

PRODUCT TYPE

162
2

Lymphoma

Lymphoma encompasses a variety of blood cancers of the lymphatic system. Non-Hodgkin’s Lymphoma (NHL) for example, is diagnosed in over 100,000 every year in the US and EU combined. An array of expert reports in our Lymphoma Section enable you to investigate drug development strategies and market trends for NHL, Hodgkin’s Lymphoma, Skin Lymphoma, T-Cell Lymphoma, Indolent Lymphoma and other variants. Investigate key issues such as licensing, R&D, industry alliances, generic drugs (rituximab, bortezomib, doxorubicin, bleomycin, vinblastine, etc.) and the activities of major pharmaceutical players such as Bristol-Myers Squibb, GlaxoSmithKline, Hoffmann-La Roche, and Sanofi-Aventis. Show Less Read more

Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  February 2016
Price:  From

Burkitt Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Burkitt Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  February 2016
Price:  From

Acute Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Acute Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase...

Published:  February 2016
Price:  From

Anaplastic Lymphoma Kinase (ALK) Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “Anaplastic Lymphoma Kinase (ALK) Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Anaplastic Lymphoma...

Published:  February 2016
Price:  From

Arranon -Drug Insights, 2016

Drug Report, “Arranon- Drug Insights, 2016” highlights the Arranon marketed details, pipeline status and the Global API Manufacturers along with the location. The report covers the Global Market Assessment...

Published:  February 2016
Price:  From

Treanda -Drug Insights, 2016

Drug Report, “Treanda- Drug Insights, 2016” highlights the Treanda marketed details, pipeline status and the Global API Manufacturers along with the location. The report covers the Global Market Assessment...

Published:  February 2016
Price:  From

Mycosis Fungoides-Pipeline Insights, 2016

“ Mycosis Fungoides-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Mycosis Fungoides. The report covers the product profiles...

Published:  February 2016
Price:  From

Cutaneous T-Cell Lymphoma-Pipeline Insights, 2016

“ Cutaneous T-Cell Lymphoma-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Cutaneous T-Cell Lymphoma. The report covers the product...

Published:  February 2016
Price:  From

B-Cell Lymphomas-Pipeline Insights, 2016

“ B-Cell Lymphomas-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the B-Cell Lymphomas. The report covers the product profiles in...

Published:  February 2016
Price:  From

Waldenstrom Macroglobulinemia-Pipeline Insights, 2016

“ Waldenstrom Macroglobulinemia-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Waldenstrom Macroglobulinemia. The report covers...

Published:  February 2016
Price:  From

Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  February 2016
Price:  From

Follicular Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Follicular Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  February 2016
Price:  From

Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  February 2016
Price:  From

Non-Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Non-Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  February 2016
Price:  From

Follicular Lymphoma-API Insights

Summary Follicular Lymphoma-API Insights, 2015 report provides Follicular Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives...

Published:  February 2016
Price:  From

Lymphoblastic Lymphoma-API Insights

Summary Lymphoblastic Lymphoma-API Insights, 2015 report provides Lymphoblastic Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report...

Published:  February 2016
Price:  From

Cutaneous T-Cell Lymphoma-API Insights

Summary Cutaneous T-Cell Lymphoma-API Insights, 2015 report provides Cutaneous T-Cell Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report...

Published:  February 2016
Price:  From

T-Cell Lymphomas Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ T-Cell Lymphomas- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

Published:  February 2016
Price:  From

Mantle Cell Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Mantle Cell Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the...

Published:  February 2016
Price:  From

Anaplastic Lymphoma Kinase (ALK) Inhibitors -Pipeline Insights

Summary Anaplastic Lymphoma Kinase (ALK) Inhibitors- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Anaplastic Lymphoma Kinase (ALK) Inhibitors. The main objective...

Published:  February 2016
Price:  From
Loading Indicator

Our Clients